comparemela.com

Latest Breaking News On - Analyst recommendations for alnylam pharmaceuticals - Page 1 : comparemela.com

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $216.19 Average PT from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]

Kentucky
United-states
Amyw-schulman
Wolfe-research
Plato-investment-management-ltd
Alnylam-pharmaceuticals-price-performance
Alnylam-pharmaceuticals-inc
Cantor-fitzgerald
Wells-fargo-company
Nasdaq
Cetera-advisors

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Recommendation of "Moderate Buy" by Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]

Canada
Wellington
New-zealand-general
New-zealand
Amyw-schulman
William-blair
Capital-research-global-investors
Alnylam-pharmaceuticals-stock-down
News-ratings-for-alnylam-pharmaceuticals-daily
Norges-bank
Alnylam-pharmaceuticals
Institutional-trading-of-alnylam-pharmaceuticals

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of "Moderate Buy" from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price target among […]

Canada
Institutional-investors-weigh-in-on-alnylam-pharmaceuticals
Jpmorgan-chase-co
Alnylam-pharmaceuticals
Royal-bank
Altitude-crest-partners-inc
Nasdaq
Alnylam-pharmaceuticals-stock-performance
Alnylam-pharmaceuticals-inc
Wolfe-research
News-ratings-for-alnylam-pharmaceuticals-daily

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $215.88 Consensus PT from Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year […]

Morgan-stanley
Alnylam-pharmaceuticals-stock-performance
Institutional-trading-of-alnylam-pharmaceuticals
Investment-management
Wolfe-research
Alnylam-pharmaceuticals
Quent-capital
Analyst-recommendations-for-alnylam-pharmaceuticals
Citigroup
Alnylam-pharmaceuticals-inc
Nasdaq

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Chardan Capital

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Chardan Capital
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

William-blair
Hedge-funds-weigh-in-on-alnylam-pharmaceuticals
Goldman-sachs-group
Nasdaq
Alnylam-pharmaceuticals
Alnylam-pharmaceuticals-inc
Cantor-fitzgerald
Alnylam-pharmaceuticals-trading
News-ratings-for-alnylam-pharmaceuticals-daily
Quent-capital
Jpmorgan-chase-co
Allspring-global-investments-holdings

vimarsana © 2020. All Rights Reserved.